23andMe laying off 14% of employees amid falling spit kit sales - STAT

23andMe laying off 14% of employees amid falling spit kit sales - STAT

23andMe laying off 14% of employees amid slump in DNA spit kit sales

By ERIN BRODWIN

NATHAN SIEMERS/CREATIVE COMMONS

In the coming months, 23andMe will focus on furthering its drug development pipeline, along with boosting sales of its at-home test kits.

READ MORE